These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24199670)

  • 1. Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?
    Chen S; Teoh NC; Chitturi S; Farrell GC
    J Gastroenterol Hepatol; 2014 Mar; 29(3):435-41. PubMed ID: 24199670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coffee and liver health.
    Morisco F; Lembo V; Mazzone G; Camera S; Caporaso N
    J Clin Gastroenterol; 2014; 48 Suppl 1():S87-90. PubMed ID: 25291138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.
    Tokushige K; Hashimoto E; Kodama K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():88-92. PubMed ID: 24251711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of coffee on liver diseases: a systematic review.
    Saab S; Mallam D; Cox GA; Tong MJ
    Liver Int; 2014 Apr; 34(4):495-504. PubMed ID: 24102757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coffee can be beneficial for patients with liver diseases].
    Kjærgaard M; Thiele M; Krag A
    Ugeskr Laeger; 2014 Oct; 176(43):. PubMed ID: 25353679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Coffee as hepatoprotective factor].
    Szántová M; Ďurkovičová Z
    Vnitr Lek; 2016; 62(12):990-997. PubMed ID: 28139128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coffee and liver diseases.
    Muriel P; Arauz J
    Fitoterapia; 2010 Jul; 81(5):297-305. PubMed ID: 19825397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.
    Salomone F; Godos J; Zelber-Sagi S
    Liver Int; 2016 Jan; 36(1):5-20. PubMed ID: 26436447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coffee and the liver: a potential treatment for liver disease?
    Masterton GS; Hayes PC
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1277-83. PubMed ID: 20802342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Bases Underlying the Hepatoprotective Effects of Coffee.
    Salomone F; Galvano F; Li Volti G
    Nutrients; 2017 Jan; 9(1):. PubMed ID: 28124992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of diet and nutritional management in non-alcoholic fatty liver disease.
    Fan JG; Cao HX
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and diagnosis of NAFLD/NASH.
    Hashimoto E; Taniai M; Tokushige K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.
    Bravi F; Bosetti C; Tavani A; Gallus S; La Vecchia C
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1413-1421.e1. PubMed ID: 23660416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.
    Ebadi M; Ip S; Bhanji RA; Montano-Loza AJ
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease.
    Yesil A; Yilmaz Y
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1038-44. PubMed ID: 24024834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coffee and nonalcoholic fatty liver disease: A review.
    Nikrandt G; Chmurzynska A
    Acta Sci Pol Technol Aliment; 2020; 19(3):245-254. PubMed ID: 32978907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine is protective in patients with non-alcoholic fatty liver disease.
    Birerdinc A; Stepanova M; Pawloski L; Younossi ZM
    Aliment Pharmacol Ther; 2012 Jan; 35(1):76-82. PubMed ID: 22059453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.
    Baffy G; Brunt EM; Caldwell SH
    J Hepatol; 2012 Jun; 56(6):1384-91. PubMed ID: 22326465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
    Marventano S; Salomone F; Godos J; Pluchinotta F; Del Rio D; Mistretta A; Grosso G
    Clin Nutr; 2016 Dec; 35(6):1269-1281. PubMed ID: 27060021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.